Genotoxicity induced by hexavalent chromium leading to eryptosis in Ctenopharyngodon idellus

K Handa, R Jindal - Chemosphere, 2020 - Elsevier
The initiation of eryptosis as a result of genotoxic action of Cr (VI), seen through
micronucleus and comet assay in the peripheral erythrocytes of Ctenopharyngodon idellus …

Assessment of the Genotoxic Potential of Azidothymidine in the Comet, Micronucleus, and Pig-a Assay

M Guérard, J Koenig, M Festag… - toxicological …, 2013 - academic.oup.com
The genotoxic potential of azidothymidine (Zidovudine, AZT), chosen as a model compound
for nucleotide analogs, was comprehensively assessed in vivo for gene mutation …

Influence of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in the evaluation of the genotoxicity of doxorubicin, cyclophosphamide and zidovudine …

L Yadav, S Khan, K Shekh, GB Jena - Mutation Research/Genetic …, 2014 - Elsevier
Testing new chemical entities for genotoxicity is an integral part of the preclinical drug-
development process. Lowering the detection limit and enhancing the sensitivity of …

Pretreatment with valproic acid, a histone deacetylase inhibitor, enhances the sensitivity of the peripheral blood micronucleus assay in rodents

T Ahmad, K Shekh, S Khan, A Vikram, L Yadav… - … /Genetic Toxicology and …, 2013 - Elsevier
Micronucleus (MN) assay is widely used for the determination of the genotoxic potential of
new chemical entities. Improvement in the sensitivity of MN assay will be advantageous for …

3-Aminobenzamide–a PARP inhibitor enhances the sensitivity of peripheral blood micronucleus and comet assays in mice

K Shekh, S Khan, G Jena, BR Kansara… - Toxicology …, 2014 - Taylor & Francis
Context: DNA repair is an essential outcome of DNA damage, which may compromise the
end point of various in vitro and in vivo test systems of the genotoxicity evaluation. poly (ADP …

Does bleeding induce micronuclei via erythropoietin in Han-Wistar rats?

J Molloy, JR Foster, H Thomas… - Toxicology …, 2014 - academic.oup.com
The effects of both intravenous administration of recombinant human erythropoietin (rhEPO)
and blood withdrawal, either individually or in combination, on the frequency of …